J Wolter

Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.

A. U. Buzdar, W. Jonat, Anthony Howell et al. · Journal of Clinical Oncology · 1996 · 410 citations · Full text

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.

Bernard Fisher, Stewart Anderson, D. Lawrence Wickerham et al. · Journal of Clinical Oncology · 1997 · 311 citations

Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.

Bernard Fisher, Carol Redmond, A Brown et al. · Journal of Clinical Oncology · 1986 · 214 citations

Life Table Probabilities, Surgical Oncology, Breast Oncology +14

Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group study.

Geoffrey Falkson, Christina Holcroft, Rebecca Gelman et al. · Journal of Clinical Oncology · 1995 · 61 citations

Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.

Philip Bonomi, Dennis Pessis, Nina A. Bünting et al. · PubMed · 1985 · 37 citations